Skip to main content

Manuel Serrano: “It makes no sense to talk about something as intangible as imortality”




Press & Communications Section Head
Tel.+34 93 40 37255

In the context of the Longevity World Forum, which will be held on 14 and 15 November in Barcelona, the specialised journal Acta Sanitaria has published an interview with IRB Barcelona researcher Manuel Serrano. “We want to understand how tissues respond to damage (and the word damage includes aging, degenerative diseases and cancer),” says the scientist.

Link to Acta Sanitaria


About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).